论文部分内容阅读
为了研究异体ＬＡＫ／ＩＬ２治疗的最佳方案，将２４例晚期肝癌分为３个不同疗程的治疗组，结果显示反复多次ＬＡＫ／ＩＬ２治疗组效果优于单次治疗组及对照组，提示ＬＡＫ／ＩＬ２治疗晚期癌症需反复多次方能有效
In order to study the best treatment of allogeneic LAK/IL-2, 24 cases of advanced liver cancer were divided into 3 different treatment groups. The results showed that repeated LAK/IL-2 treatment group was better than single treatment group and control Group, suggesting that LAK/IL-2 treatment for advanced cancer needs multiple iterations to be effective